J H Botha1, M J du Preez, M Adhikari. 1. Department of Experimental and Clinical Pharmacology, Nelson R. Mandela School of Medicine, Private Bag 7, 4013, Congella, South Africa. botha@nu.ac.za
Abstract
OBJECTIVE: Gentamicin population pharmacokinetics in newborns were studied with special reference to possible gender effects. METHODS: Steady-state serum levels ( n=139) were obtained from 79 neonates with a mean birth weight of 2.1 kg, mean gestational age of 35.1 weeks and mean age at the time of sampling of 4.2 days. The data were analysed using the non-linear mixed effects model (NONMEM). A one-compartment model was used to fit the data. RESULTS: The final models for clearance (CL) and volume of distribution (V) were: CL(l/h)=0.001xWGTxGAxP and V(l)=0.472xWGT, where WGT=birth weight (kg), GA=gestational age (weeks) and P=1.2 for girls and 1.0 for boys. The values of inter-individual variability in CL and V were 34% and 35%, respectively. Intra-individual variability was 5% (proportional) and 7.2% (additive). Mean (95% confidence interval) values of CL and half-life were 0.042 l h(-1) kg(-1) (0.041, 0.043 l h(-1) kg(-1)) and 8.0 h (7.7, 8.3 h), while V was 0.472 (0.428, 0.516) l/kg for all patients. CONCLUSION: Mean population pharmacokinetic values were similar to those obtained with NONMEM for gentamicin in other neonates of similar age. Gender was found to be a determinant of CL, with girls clearing faster than boys.
OBJECTIVE:Gentamicin population pharmacokinetics in newborns were studied with special reference to possible gender effects. METHODS: Steady-state serum levels ( n=139) were obtained from 79 neonates with a mean birth weight of 2.1 kg, mean gestational age of 35.1 weeks and mean age at the time of sampling of 4.2 days. The data were analysed using the non-linear mixed effects model (NONMEM). A one-compartment model was used to fit the data. RESULTS: The final models for clearance (CL) and volume of distribution (V) were: CL(l/h)=0.001xWGTxGAxP and V(l)=0.472xWGT, where WGT=birth weight (kg), GA=gestational age (weeks) and P=1.2 for girls and 1.0 for boys. The values of inter-individual variability in CL and V were 34% and 35%, respectively. Intra-individual variability was 5% (proportional) and 7.2% (additive). Mean (95% confidence interval) values of CL and half-life were 0.042 l h(-1) kg(-1) (0.041, 0.043 l h(-1) kg(-1)) and 8.0 h (7.7, 8.3 h), while V was 0.472 (0.428, 0.516) l/kg for all patients. CONCLUSION: Mean population pharmacokinetic values were similar to those obtained with NONMEM for gentamicin in other neonates of similar age. Gender was found to be a determinant of CL, with girls clearing faster than boys.
Authors: A W Kelman; A H Thomson; B Whiting; S M Bryson; D A Steedman; G E Mawer; L A Samba-Donga Journal: Br J Clin Pharmacol Date: 1984-11 Impact factor: 4.335
Authors: Gudrun Würthwein; Andreas H Groll; Georg Hempel; Felice C Adler-Shohet; Jay M Lieberman; Thomas J Walsh Journal: Antimicrob Agents Chemother Date: 2005-12 Impact factor: 5.191
Authors: Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt Journal: Curr Clin Pharmacol Date: 2014
Authors: Tamara van Donge; Marc Pfister; Julia Bielicki; Chantal Csajka; Frederique Rodieux; John van den Anker; Aline Fuchs Journal: Antimicrob Agents Chemother Date: 2018-03-27 Impact factor: 5.191
Authors: Elisabet I Nielsen; Marie Sandström; Per Hartvig Honoré; Uwe Ewald; Lena E Friberg Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447
Authors: Michiel F Schreuder; Abraham J Wilhelm; Arend Bökenkamp; Simone M H Timmermans; Henriette A Delemarre-van de Waal; Joanna A E van Wijk Journal: Clin J Am Soc Nephrol Date: 2009-08-27 Impact factor: 8.237
Authors: Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin Journal: Clin Pharmacokinet Date: 2014-07 Impact factor: 6.447
Authors: Eva Germovsek; Alison Kent; Tuuli Metsvaht; Irja Lutsar; Nigel Klein; Mark A Turner; Mike Sharland; Elisabet I Nielsen; Paul T Heath; Joseph F Standing Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191